Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

Research and Innovation Action · Running

AIDA An Artificially Intelligent Diagnostic Assistant for gastric inflammation

Coordinator
Fundacion Para La Investigacion Del Hospital Clinico De La Comunitat Valenciana, Fundacion Incliva, Spain
Runs
1 January 2023 to 31 December 2026
Status
Running
EU funding
€6.3m
Total cost
€6.3m
Partners
15 organisations in 8 countries
Type
Research and Innovation Action
Grant agreement
101095359

What the project is doing

In the project's own words, from its summary on CORDIS.

Most cases of gastric cancer (GC) are detected at a late stage, when patients have a median life expectancy of about a year. Diagnosing people at risk of developing GC at the pre-symptomatic stage, typically chronic gastric inflammation, could significantly improve the outlook. Artificial intelligence (AI) can help clinicians make sense of their own data by automating much of the treatment and analysis, which require manual work and years of experience.

But it can do more: it can bring together available data from various sources into a vast data lake and cross-correlate the data to derive a ‘risk score’ for gastric cancer and shed light on the mechanisms of its evolution. Aida aims to do just that. It helps researchers understand the mechanisms that trigger gastric oncogenesis, helps clinicians diagnose precancerous inflammation at the earliest possible stage, suggests personalised therapeutic strategies for treatment and follow-up, and makes personalised recommendations for monitoring patient health status, thus contributing to gastric cancer prevention.

This places Aida squarely on Europe’s agenda of ‘Staying healthy in a rapidly changing society’. Aida unites some of Europe’s leading authorities in the field of gastric inflammation, gastric cancer, leading AI and machine learning experts, experts on data governance and privacy, representatives of the public administration and patient advocates. Aida also has strong ties with the industry. After the project, the results will live on in an association that acts as a transnational focal point for chronic gastric inflammation — and GC in general.

We hope that the solid, inclusive design principles of Aida, its societal relevance and its durability will spawn a vigorous ecosystem around chronic gastric inflammation, its understanding and its treatment. And we hope that it will inspire other data collaboratives in health — for other chronic inflammations, other forms of cancer or other ailments altogether.

Topics

Who is involved

OrganisationCityCountryRole
Fundacion Para La Investigacion Del Hospital Clinico De La Comunitat Valenciana, Fundacion InclivaValenciaSpainCoordinator
Digestive Cancers Europe DiceBruxelles / BrusselBelgiumParticipant
StratejaiBrusselsBelgiumParticipant
Fundacio De Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi I SunyerBarcelonaSpainParticipant
Fundacion Para La Investigacion Biomedica Del Hospital Universitario La PrincesaMadridSpainThird party
Hospital Clinic De BarcelonaBarcelonaSpainThird party
Servicio Madrileno De SaludMadridSpainParticipant
Centre Hospitalier Universitaire De NantesNantesFranceParticipant
Nantes UniversiteNantesFranceThird party
Lietuvos Sveikatos Mokslu Universiteto Ligonine Kauno KlinikosKaunasLithuaniaParticipant
Latvijas UniversitateRigaLatviaParticipant
Erasmus Universitair Medisch Centrum RotterdamRotterdamNetherlandsParticipant
I3s - Instituto De Investigacao E Inovacao Em Saude Da Universidade Do PortoPortoPortugalParticipant
Instituto Portugues De Oncologia Do Porto Francisco Gentil, EpePortoPortugalParticipant
Imperial College of Science Technology and MedicineLondonUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI